Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1059-1066
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1059
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1059
Table 2 Adverse effects after bismuth-based quadruple therapy n (%)
Patients (n = 495) | |
Side effect | 74 (14.9) |
Diarrhea | 16 (3.2) |
Bloating or abdominal pain | 22 (4.4) |
Nausea or vomiting | 26 (5.3) |
Others1 | 10 (2.0) |
- Citation: Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1059.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1059